Latest Financial Position News

Oneview Healthcare PLC reported a 36% increase in revenue for the first half of 2025, driven by strong deployment activity and new US customers, while managing a wider net loss due to FX impacts and restructuring costs.

Amotiv Limited has announced a fully franked ordinary dividend of AUD 0.22 per share for the financial year ending June 2025, payable in September. The dividend reflects the company’s steady financial position and commitment to shareholder returns.

Insurance Australia Group Limited (IAG) has announced an ordinary dividend of AUD 0.19 per share for the six months ending June 2025, offering investors a partially franked payout with a Dividend Reinvestment Plan available.

My Foodie Box Limited reported a significantly reduced net loss for the half year ended December 2024 following the divestment of its meal kit business. The company is actively pursuing new acquisitions and funding to restore shareholder value and regain its ASX listing.

Computershare Limited reported a 72% surge in net profit for FY25, driven by strong fee revenue growth and disciplined cost management despite a 5.6% revenue decline due to a major business disposal. The company also announced a higher final dividend and ongoing strategic acquisitions.

Energy Transition Minerals Ltd has issued over 238 million shares to OCJ Investment and updated its Share Purchase Plan timetable to raise up to $3 million, signaling a strategic capital boost.

Energy Transition Minerals has completed a $10 million strategic placement with OCJ Investment and appointed mining veteran Amy Jiang as a Non-Executive Director, signaling a strengthened governance and growth trajectory.

Brisbane Broncos Limited projects a net profit before tax of $8.69 million for H1 2025, up from $6.30 million a year earlier, driven by an additional NRL home game and stronger revenues across ticketing, sponsorship, and merchandise.

Nutritional Growth Solutions Ltd has clarified discrepancies in its June 2025 quarterly reports, attributing changes to timing and classification adjustments, while reaffirming its financial health and governance compliance.

WAM Capital Limited’s July 2025 update reveals a robust net tangible asset position and a healthy interim dividend, underpinned by strong performances from key holdings ALS and HUB24.

LGI Limited reported a robust FY25 with a 13.6% increase in underlying EBITDA to $17.4 million, expanded renewable capacity by 44%, and declared a fully franked dividend. The company’s strategic investments in battery storage and biogas infrastructure position it well in Australia’s energy transition.

Tryptamine Therapeutics has locked in $2.6 million in non-dilutive funding to fast-track clinical trials of its lead psilocin-based therapy, TRP-8803, targeting binge eating disorder and other conditions.